World Flu Day 2024 Symposium / 9th Japan-China Bilateral Symposium on All Influenza VirusesWorld Flu Day 2024 Symposium / 9th Japan-China Bilateral Symposium on All Influenza Viruses

Program

Program at a Glance

Nov. 1 ( Fri. )
Time Program Speaker Title Chairs
9:00〜9:05 Opening remark
9:05〜9:35 Invited speaker 01 Hualan Chen Mysteries of influenza virus infection and pathogenicity
Chairs:
Amy Baker, Yasuyuki Miyake
Amy Baker
Yasuyuki Miyake
9:35〜10:05 Invited speaker 02 Tokiko Watanabe A strategy for virus survival: the genetic diversity and host adaptation of SARS-CoV-2
Chairs:
Amy Baker, Yasuyuki Miyake
10:05〜10:35 Invited speaker 03 Jinhua Liu Prevalence and control of H9N2 subtype avian influenza virus
Chairs:
Amy Baker, Yasuyuki Miyake
10:35〜10:45 Coffee break (10min)
10:45〜11:15 Invited speaker 04 Katherine Kedzierska Defining host factors underpinning life-threatening respiratory viral diseases
Chairs:
William Jun Liu, Tokiko Watanabe
William Jun Liu
Tokiko Watanabe
11:15〜11:45 Invited speaker 05 Atsushi Kawaguchi Myocarditis induced by inflammatory response in peripheral tissues upon influenza A virus infection
Chairs:
William Jun Liu, Tokiko Watanabe
11:45〜12:00 Oral presentation 01 Chengjun Li Interplay between host cellular factors and vRNP complex of influenza A virus
Chairs:
William Jun Liu, Tokiko Watanabe
12:00〜12:15 Oral presentation 02 Yipeng Sun Escaping from restriction of RNF2-mediated NA protein degradation promotes adaptation of avian influenza virus to mammals
Chairs:
William Jun Liu, Tokiko Watanabe
12:30〜13:20 Lunch (50min)
13:30〜14:00 Invited speaker 06 Yasuyuki Miyake Molecular insights into assembled genome structure of influenza A virus during uncoating
Chairs:
Hui-Ling Yen, Tadaki Suzuki
Hui-Ling Yen
Tadaki Suzuki
14:00〜14:30 Invited speaker 07 Colin Russell Global solidarity in genomic surveillance improves early detection of respiratory virus threats
Chairs:
Hui-Ling Yen, Tadaki Suzuki
14:30〜14:45 Oral presentation 03 Taijiao Jiang Modeling Influenza Antigenic Evolution with PREDAC
Chairs:
Hui-Ling Yen, Tadaki Suzuki
14:45〜15:00 Oral presentation 04 Kelvin To Intrahost evolution: a sneak peek to the future
Chairs:
Hui-Ling Yen, Tadaki Suzuki
15:00〜15:10 Coffee break (10min)
15:10〜15:40 Invited speaker 08 Hui-Ling Yen Antibodies against influenza virus neuraminidase
Chairs:
Takeshi Ichinohe, Wenqing Zhang
Takeshi Ichinohe
Wenqing Zhang
15:40〜16:10 Invited speaker 09 Yoshimasa Takahashi Hide and seek between flu and antibody
Chairs:
Takeshi Ichinohe, Wenqing Zhang
16:10〜16:40 Invited speaker 10 Tadaki Suzuki Application of SIgA Multimerization and Anti-Idiotype Antibodies to Induce Broadly Neutralizing Antibodies Against Influenza Virus
Chairs:
Takeshi Ichinohe, Wenqing Zhang
16:40〜16:55 Oral presentation 05 Shiho Chiba Protective mechanisms of human monoclonal antibodies cross-reactive against antigenically divergent influenza H3HA
Chairs:
Takeshi Ichinohe, Wenqing Zhang
16:55〜17:05 Coffee break (10min)
17:05〜17:35 Invited speaker 11 Amy Baker Viral replication and disease in dairy calves and lactating cows inoculated with highly pathogenic avian influenza H5N1 clade 2.3.4.4b
Chairs:
Yuhai Bi, Hualan Chen
Yuhai Bi
Hualan Chen
17:35〜18:05 Invited speaker 12 George Gao The scientific preparation for pandemic threats of emerging H5N1s
Chairs:
Yuhai Bi, Hualan Chen
18:05〜18:30 Free time
18:30〜20:30 Social (120 min)
Nov. 2 ( Sat. )
Time Program Speaker Title Chairs
8:45〜9:30 Session for Young Scientists Flu Clash: Emerging Researchers' Edition
9:30〜10:00 Invited speaker 13 Wenqing Zhang A Global Perspective of Surveillance, Preparedness and Response to the Next Influenza Pandemic
Chairs:
Colin Russell, Yoshimasa Takahashi
Colin Russell
Yoshimasa Takahashi
10:00〜10:30 Invited speaker 14 Yuhai Bi Dual receptor-binding, infectivity, and transmissibility of an emerging H2N2 low pathogenicity avian influenza virus
Chairs:
Colin Russell, Yoshimasa Takahashi
10:30〜10:45 Oral presentation 06 Takahiro Hiono Redefining the sialoside receptor distributions in birds and mammals
Chairs:
Colin Russell, Yoshimasa Takahashi
10:45〜10:55 Coffee break (10min)
10:55〜11:25 Invited speaker 15 Takeshi Ichinohe High body temperature increases gut microbiota-dependent host resistance to influenza A virus infection
Chairs:
Katherine Kedzierska, Atsushi Kawaguchi
Katherine Kedzierska
Atsushi Kawaguchi
11:25〜11:55 Invited speaker 16 William Jun Liu Preserved and Evaded Antigen-specific T cell Immunity in Flu and COVID
Chairs:
Katherine Kedzierska, Atsushi Kawaguchi
11:55〜12:10 Oral presentation 07 Masashi Shingai Inactivated whole influenza virus particle vaccine showed balanced immunogenicity and safety
Chairs:
Katherine Kedzierska, Atsushi Kawaguchi
12:10〜12:25 Oral presentation 08 Tao Deng Influenza A virus NS2 protein acts as a transcription to replication switch
Chairs:
Katherine Kedzierska, Atsushi Kawaguchi
12:25〜12:30 Closing remark

Confirmed Speakers

Invited speaker 01

Mysteries of influenza virus infection and pathogenicity

Hualan Chen

Harbin Veterinary Research Institute, CAAS, China

Invited speaker 02

A strategy for virus survival: the genetic diversity and host adaptation of SARS-CoV-2

Tokiko Watanabe

Research Institute for Microbial Diseases, Osaka University

Invited speaker 03

Prevalence and control of H9N2 subtype avian influenza virus

Jinhua Liu

China Agricultural University, China

Invited speaker 04

Defining host factors underpinning life-threatening respiratory viral diseases

Katherine Kedzierska

University of Melbourne and Doherty Institute, Australia

Invited speaker 05

Myocarditis induced by inflammatory response in peripheral tissues upon influenza A virus infection

Atsushi Kawaguchi

Institute of Medicine, University of Tsukuba

Invited speaker 06

Molecular insights into assembled genome structure of influenza A virus during uncoating

Yasuyuki Miyake

Nagoya University

Invited speaker 07

Global solidarity in genomic surveillance improves early detection of respiratory virus threats

Colin Russell

University of Amsterdam, The Netherlands

Invited speaker 08

Antibodies against influenza virus neuraminidase

Hui-Ling Yen

School of Public Health, The University of Hong Kong, China

Invited speaker 09

Hide and seek between flu and antibody

Yoshimasa Takahashi

National Institute of Infectious Diseases, Research Center for Drug and Vaccine Development

Invited speaker 10

Application of SIgA Multimerization and Anti-Idiotype Antibodies to Induce Broadly Neutralizing Antibodies Against Influenza Virus

Tadaki Suzuki

National Institute of Infectious Diseases

Invited speaker 11

Viral replication and disease in dairy calves and lactating cows inoculated with highly pathogenic avian influenza H5N1 clade 2.3.4.4b

Amy Baker

US Dept. of Agriculture National Animal Disease Center, USA

Invited speaker 12

The scientific preparation for pandemic threats of emerging H5N1s

George Gao

Chinese Center for Disease Control and Prevention / Chinese Academy of Sciences, China

Invited speaker 13

A Global Perspective of Surveillance, Preparedness and Response to the Next Influenza Pandemic

Wenqing Zhang

the Head of the Global Influenza Program of WHO, Switzerland

Invited speaker 14

Dual receptor-binding, infectivity, and transmissibility of an emerging H2N2 low pathogenicity avian influenza virus

Yuhai Bi

Chinese Academy of Sciences, China

Invited speaker 15

High body temperature increases gut microbiota-dependent host resistance to influenza A virus infection

Takeshi Ichinohe

Institute of Medical Science, the University of Tokyo

Invited speaker 16

Preserved and Evaded Antigen-specific T cell Immunity in Flu and COVID

William Jun Liu

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC)

Oral presentation 01

Interplay between host cellular factors and vRNP complex of influenza A virus

Chengjun Li

the Chinese Academy of Agricultural Sciences, China

Oral presentation 02

Escaping from restriction of RNF2-mediated NA protein degradation promotes adaptation of avian influenza virus to mammals

Yipeng SUN

China agricultural university

Oral presentation 03

Modeling Influenza Antigenic Evolution with PREDAC

Taijiao Jiang

Guangzhou National Laboratory, China

Oral presentation 04

Intrahost evolution: a sneak peek to the future

Kelvin To

Hong Kong University, China

Oral presentation 05

Protective mechanisms of human monoclonal antibodies cross-reactive against antigenically divergent influenza H3HA

Shiho Chiba

the University of Tokyo

Oral presentation 06

Redefining the sialoside receptor distributions in birds and mammals

Takahiro Hiono

Hokkaido University

Oral presentation 07

Inactivated whole influenza virus particle vaccine showed balanced immunogenicity and safety

Masashi Shingai

Hokkaido University

Oral presentation 08

Influenza A virus NS2 protein acts as a transcription to replication switch

Tao Deng

Chinese Academy of Sciences, China

Luncheon Seminar

The clinical effectiveness of baloxavir marboxil in treating Influenza A(H1N1)pdm09, A(H3N2), and B and the emergence of PA variants that confer reduced susceptibility

Reiko Saito

Niigata University

as of October 28, 2024